Question assumptions. Follow the data.
We combine established genomic knowledge with research-stage signals, aiming to surface information that narrower tests may not examine.
A comprehensive genome scan designed to look beyond the obvious — examining your DNA across all chromosomes and organizing relevant findings into a clear, human-readable report.
Chromosight is a young, ambitious genomics startup built around a simple idea: standard answers are not always enough. Our team brings together scientific curiosity, technology and laboratory biomedicine expertise to investigate genomic data with a broader perspective.
We combine established genomic knowledge with research-stage signals, aiming to surface information that narrower tests may not examine.
Our team includes people with a background connected to university-level laboratory biomedicine, bringing scientific discipline into the product.
Chromosight analyzes whole-genome data from chromosome to chromosome, screening observed variants against established pathology knowledge and research-stage evidence. The result is organized into a report designed for informed review — not a black box.
The analysis is designed around genome-wide data rather than a small set of predefined genes, providing a broader foundation for variant review.
Findings can be compared with curated knowledge on established pathogenic variants and relevant research-stage observations.
Selected genetically influenced traits can be included as an additional sample-consistency check, helping flag an accidental sample mix-up.
Where available, telomere-length information can be presented as a rough biomarker associated with cellular aging. It should not be interpreted as a standalone measure of biological age or overall health.
Across autosomes and sex chromosomes, subject to sample and sequencing quality.
The report is designed to separate different kinds of findings clearly: established clinical relevance, research-stage signals, selected traits and quality/identity checks.
A structured overview helps you understand what was found, how strong the underlying evidence is, and which results may need professional clinical interpretation.
Two clear options for customers who want a broad genomic overview or a more extensive premium analysis. Final scope, turnaround time and included report elements can be specified before launch.
A comprehensive entry point for whole-genome analysis and structured reporting.
A deeper premium review for customers who want the broadest level of genomic investigation.
Talk to us about availability, sample collection, report scope and which analysis is the right fit for you.